FZCM
GILD icon

Flynn Zito Capital Management’s Gilead Sciences GILD Stock Holding History

Flynn Zito Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
1,881
+158
+9% +$20.8K 0.06% 142
2026
Q1 		$240K Hold
1,723
– – 0.08% 130
2025
Q4 		$211K Buy
+1,723
New +$209K 0.08% 131

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Flynn Zito Capital Management's GILD Position: Q2 2026 in Review

Flynn Zito Capital Management increased its Gilead Sciences (GILD) stake by 9.2% in Q2 2026, buying an estimated $20.8K and bringing the position to 1,881 shares worth $238K. The position accounts for 0.06% of the portfolio, ranked #142.

Flynn Zito Capital Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $240K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Flynn Zito Capital Management held 1,881 shares of Gilead Sciences worth $238K as of Q2 2026.
  • Flynn Zito Capital Management bought 158 Gilead Sciences shares in Q2 2026, an estimated $20.8K.
  • Gilead Sciences made up 0.06% of Flynn Zito Capital Management's portfolio in Q2 2026, its #142 holding.
  • Flynn Zito Capital Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Flynn Zito Capital Management's Gilead Sciences position peaked at $240K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Flynn Zito Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.